Insider Ledger
RLMD insider buying and SEC filings, explained
Relmada Therapeutics, Inc. · CIK 1553643
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- NV
- Fiscal year end
- Dec 31
- Former names
- CAMP NINE, INC.
Insider activity in the last 12 months
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 9–10, 2026 | Open-market purchase | Maged Shenouda (CFO) bought 200,000 shares between Sep 9 and Sep 10 at about $4.22 ($844K) in an open-market purchase. Holdings up 25% to 1,000,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Sep 9–10, 2026 | Open-market purchase | Sergio Traversa (CEO and Director) bought 200,000 shares between Sep 9 and Sep 10 at about $4.14 ($828K) in an open-market purchase. Holdings up 15% to 1,500,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 11, 2026 |
| Dec 15, 2025 | Open-market purchase | Sergio Traversa (CEO and Director) bought 27,500 shares at about $4.12 ($113K) in an open-market purchase. Holdings up 2% to 1,300,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 16, 2025 |
| Dec 15, 2025 | Purchase (code P) | Maged Shenouda (CFO) bought 11,665 shares at $4.12 ($48K), reported as a purchase (code P). Holdings up 1% to 800,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 16, 2025 |
| Nov 5, 2025 | Purchase (code P) | Chuck Ence (President / COO) bought 136,000 shares at $2.20 ($299K), reported as a purchase (code P). Holdings up 51% to 403,931 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
| Nov 5, 2025 | Purchase (code P) | Sergio Traversa (CEO and Director) bought 272,500 shares at $2.20 ($600K), reported as a purchase (code P). Holdings up 27% to 1,272,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
| Nov 5, 2025 | Purchase (code P) | Maged Shenouda (CFO) bought 500,000 shares at $2.20 ($1.1M), reported as a purchase (code P). Holdings up 173% to 788,335 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
| Nov 5, 2025 | Purchase (code P) | Paul Edward Kelly (President / COO and Director) bought 90,000 shares at $2.20 ($198K), reported as a purchase (code P). Holdings up 22% to 502,295 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 6, 2025 |
7 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$1.7M in purchases since Sep 10, 2026 · Purchases traded Sep 10, 2026 to Sep 10, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Sergio Traversa (CEO) | $828K | Sep 10, 2026 | SEC filing |
| Maged Shenouda (CFO) | $844K | Sep 10, 2026 | SEC filing |
2 insiders bought in 30 days
$161K in purchases since Dec 15, 2025 · Purchases traded Dec 15, 2025 to Dec 15, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Maged Shenouda (CFO) | $48K | Dec 15, 2025 | SEC filing |
| Sergio Traversa (CEO) | $113K | Dec 15, 2025 | SEC filing |
4 insiders bought in 30 days
$2.2M in purchases since Nov 5, 2025 · Purchases traded Nov 5, 2025 to Nov 5, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Paul Edward Kelly (President / COO) | $198K | Nov 5, 2025 | SEC filing |
| Maged Shenouda (CFO) | $1.1M | Nov 5, 2025 | SEC filing |
| Sergio Traversa (CEO) | $600K | Nov 5, 2025 | SEC filing |
| Chuck Ence (President / COO) | $299K | Nov 5, 2025 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.